Brad Hively
Chief Executive Officer at Starling Oncology Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Starling Oncology Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Starling Oncology Inc. June 17, 202694.2%
-
Starling Oncology Inc. May 7, 202588.2%
-
Starling Oncology Inc. June 13, 202497.5%
-
Starling Oncology Inc. June 15, 202398.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Starling Oncology Inc. | Open-market sale | −298,853 | $6.51 | $1,945,533 |
| Jul 27, 2026 | Starling Oncology Inc. | Grant or award | +27,108 | — | — |
| Dec 15, 2025 | Starling Oncology Inc. | Open-market sale | −13,333 | $3.77 | $50,265 |
| Nov 20, 2025 | Starling Oncology Inc. | Grant or award | +41,667 | — | — |
| Nov 20, 2025 | Starling Oncology Inc. | Grant or award | +32,407 | — | — |
| Aug 19, 2025 | Starling Oncology Inc. | Open-market sale | −20,221 | $4.06 | $82,097 |
| Jun 3, 2025 | Starling Oncology Inc. | Option exercise | +684,528 | $0.85 | $581,849 |
| Jun 3, 2025 | Starling Oncology Inc. | Option exercise | +105,320 | $0.48 | $50,554 |
| Jun 3, 2025 | Starling Oncology Inc. | Option exercise | +131,297 | $1.87 | $245,525 |
| Jun 3, 2025 | Starling Oncology Inc. | Option exercise | +946,460 | $0.85 | $804,491 |
| Jun 3, 2025 | Starling Oncology Inc. | Open-market sale | −1,867,605 | $2.87 | $5,360,026 |
| Jun 3, 2025 | Starling Oncology Inc. | Open-market sale | −108,532 | $2.87 | $311,487 |
| Mar 26, 2025 | Starling Oncology Inc. | Open-market purchase | +9,056 | $1.04 | $9,418 |
| Dec 2, 2024 | Starling Oncology Inc. | Open-market purchase | +50,000 | $0.15 | $7,500 |
| Nov 26, 2024 | Starling Oncology Inc. | Open-market purchase | +250,000 | $0.17 | $42,500 |
Questions about Brad Hively
What boards is Brad Hively on?
Brad Hively sits on the board of Starling Oncology Inc.
What company is Brad Hively the CEO of?
Brad Hively is Chief Executive Officer of Starling Oncology Inc.
How long has Brad Hively served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.